Newsletter Archive

41. 10.12.20 -- Bayer Overhauls Its Clinical Trial Planning Process 10/12/2020
    10/12/20 Clinical Leader Newsletter
42. 10.08.20 -- New Podcast Episodes: Data Quality For FDA Submissions, CMC Considerations For FIH Studies, And More 10/8/2020
    10/08/20 Clinical Leader Newsletter
43. 10.07.20 -- New Report Focuses On Clinical Trial Disruption And The Impact On IRT 10/7/2020
    10/07/20 Clinical Leader Newsletter
44. 10.06.20 -- The Importance Of Site/Sponsor Partnerships In The New Normal 10/6/2020
    10/06/20 Clinical Leader Newsletter
45. 10.05.20 -- Will Virtual Trials Mean The End Of CROs? 10/5/2020
    10/05/20 Clinical Leader Newsletter
46. 10.05.20 -- A Pandemic Playbook: Executing Decentralized Trials Successfully 10/5/2020
    10/05/20 Clinical Leader Newsletter
47. 09.30.20 -- How The FDA Is Helping Advance Clinical Trial Diversity 9/30/2020
    09/30/20 Clinical Leader Newsletter
48. 09.30.20 -- Unlock Competitive Advantage With AI And Advanced Analytics 9/30/2020
    09/30/20 Clinical Leader Newsletter
49. 09.30.20 -- Industry Trends In Clinical Development Technology 9/30/2020
    09/30/20 Clinical Leader Newsletter
50. 09.29.20 -- How To Leverage Remote Site Access Technology In Clinical Trials 9/29/2020
    09/29/20 Clinical Leader Newsletter